Le Lézard

Envestnet Unveils Trading, Reporting, and Technology Enhancements to Its Tamarac Platform, Live from the Mainstage at Elevate 2026

Envestnet, the leading Adaptive WealthTech company, today announced the latest product enhancements on its Tamarac platform, delivering new capabilities designed to help financial advisors manage ...

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Favourable trends seen in stability of disability and clinically meaningful improvements in fatigue.BOSTON, May 19, 2026 ...

Tiziana Life Sciences Ltd.: Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Favourable trends seen in stability of disability and clinically meaningful improvements in fatigue. BOSTON, May 19, 2026 ...

Ipsen Pharma: Ipsen announces late-breaking data from first head-to-head study comparing Dysport and Botox in adults with upper limb spasticity

Phase IV head-to-head, double-blind trial comparing safety and efficacy met its primary and secondary endpointsThe DIRECTION trial results show the safety profile for Dysport (abobotulinumtoxinA) was ...